Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Elgohary, NahlaPellegrino, Rossella
Neumann, Olaf
Elzawahry, Heba M
Saber, Magdy M
Zeeneldin, Ahmed A
Geffers, Robert

Ehemann, Volker
Schemmer, Peter
Schirmacher, Peter
Longerich, Thomas
Issue Date
2015-02
Metadata
Show full item recordAbstract
The mammalian timeless (TIM) protein interacts with proteins of the endogenous clock and essentially contributes to the circadian rhythm. In addition, TIM is involved in maintenance of chromosome integrity, growth control and development. Thus, we hypothesized that TIM may exert a potential protumorigenic function in human hepatocarcinogenesis. TIM was overexpressed in a subset of human HCCs both at the mRNA and the protein level. siRNA-mediated knockdown of TIM reduced cell viability due to the induction of apoptosis and G2 arrest. The latter was mediated via CHEK2 phosphorylation. In addition, siRNA-treated cells showed a significantly reduced migratory capacity and reduced expression levels of various proteins. Mechanistically, TIM directly interacts with the eukaryotic elongation factor 1A2 (EEF1A2), which binds to actin filaments to promote tumor cell migration. siRNA-mediated knockdown of TIM reduced EEF1A2 protein levels thereby affecting ribosomal protein biosynthesis. Thus, overexpression of TIM exerts oncogenic function in human HCCs, which is mediated via CHEK2 and EEF1A2.Citation
Protumorigenic role of Timeless in hepatocellular carcinoma. 2015, 46 (2):597-606 Int. J. Oncol.Affiliation
Helmholtz Centre for infection research, Inhoffenstr. 7, 38124 Braunschweig, Germany.PubMed ID
25405317Type
ArticleLanguage
enISSN
1791-2423ae974a485f413a2113503eed53cd6c53
10.3892/ijo.2014.2751
Scopus Count
The following license files are associated with this item:
Related articles
- SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth.
- Authors: Jin T, Fu J, Feng XJ, Wang SM, Huang X, Zhu MH, Zhang SH
- Issue date: 2013 Sep
- Disturbance of circadian gene expression in hepatocellular carcinoma.
- Authors: Lin YM, Chang JH, Yeh KT, Yang MY, Liu TC, Lin SF, Su WW, Chang JG
- Issue date: 2008 Dec
- ERK-mediated TIMELESS expression suppresses G2/M arrest in colon cancer cells.
- Authors: Neilsen BK, Frodyma DE, McCall JL, Fisher KW, Lewis RE
- Issue date: 2019
- Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma.
- Authors: Zhang SH, Qian YM, Liu AW, Cai J, Zhao XL, Wei JJ, Zhu MH
- Issue date: 2012 Jul
- An unexpected role for the clock protein timeless in developmental apoptosis.
- Authors: O'Reilly LP, Watkins SC, Smithgall TE
- Issue date: 2011 Feb 17